Lifecare AS (LIFE.OL)

NOK 14.0

(-6.35%)

EBITDA Summary of Lifecare AS

Lifecare AS's latest annual EBITDA in 2023 was -32.09 Million NOK , down -126.01% from previous year.
Lifecare AS's latest quarterly EBITDA in 2024 Q1 was -12.05 Million NOK , up 19.85% from previous quarter.
Lifecare AS reported an annual EBITDA of -14.61 Million NOK in 2022, up 7.65% from previous year.
Lifecare AS reported an annual EBITDA of -15.38 Million NOK in 2021, down -526.18% from previous year.
Lifecare AS reported a quarterly EBITDA of -12.05 Million NOK for 2024 Q1, up 19.85% from previous quarter.
Lifecare AS reported a quarterly EBITDA of -6.05 Million NOK for 2023 Q3, up 9.15% from previous quarter.

Annual EBITDA Chart of Lifecare AS (2023 - 2015)

Historical Annual EBITDA of Lifecare AS (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-32.09 Million NOK	-126.01%
2022	-14.61 Million NOK	7.65%
2021	-15.38 Million NOK	-526.18%
2020	-2.58 Million NOK	62.42%
2019	-6.53 Million NOK	24.88%
2018	-8.7 Million NOK	-155.76%
2017	-3.4 Million NOK	30.73%
2016	-4.91 Million NOK	34.37%
2015	-7.48 Million NOK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-17.48 Million NOK	-50.01%
2024 Q1	-12.05 Million NOK	19.85%
2023 Q3	-6.05 Million NOK	9.15%
2023 Q1	-5.69 Million NOK	31.34%
2023 Q4	-14.54 Million NOK	-140.19%
2023 FY	- NOK	-126.01%
2023 Q2	-6.66 Million NOK	-16.93%
2022 Q4	-8.3 Million NOK	-2200.81%
2022 Q2	-1.15 Million NOK	0.0%
2022 FY	- NOK	7.65%
2022 Q3	395.13 Thousand NOK	134.16%
2021 FY	- NOK	-526.18%
2020 FY	- NOK	62.42%
2019 FY	- NOK	24.88%
2018 FY	- NOK	-155.76%
2017 FY	- NOK	30.73%
2016 FY	- NOK	34.37%
2015 FY	- NOK	0.0%

Peer EBITDA Comparison of Lifecare AS

Name	EBITDA	EBITDA Difference
Gentian Diagnostics ASA	-3.92 Million NOK	-718.542%
Medistim ASA	155.09 Million NOK	120.693%